These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3526662)

  • 1. Assessment of primarily vascularized cardiac allografts in mice.
    Superina RA; Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1986 Aug; 42(2):226-7. PubMed ID: 3526662
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked prolongation of incompatible class I deficient heart allografts: paradoxical effects between primarily and secondarily vascularized allografts.
    Henretta J; Araneda D; Pittman K; Thomas F
    Transplant Proc; 1995 Feb; 27(1):1303-4. PubMed ID: 7878892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies used to alter the immunogenicity of vascularized organ allografts.
    Pollak R; Blanchard JM; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):258-61. PubMed ID: 3547820
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 6. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
    Pan F; Valdivia LA; Tsugita M; Celli S; Haeuchi K; Demetris AJ; Avci G; Fung JJ
    Transplant Proc; 1994 Jun; 26(3):1211. PubMed ID: 7518113
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular changes in experimental cardiac allografts.
    Laden AM; Sinclair RA; Ruskiewicz M
    Transplant Proc; 1973 Mar; 5(1):737-9. PubMed ID: 4572134
    [No Abstract]   [Full Text] [Related]  

  • 9. Residual antigenicity and its management after removal of vascularized grafts.
    Harihara Y; Sanjo K; Otsubo O; Watanabe G; Tsurumaru M; Idezuki Y
    Transplant Proc; 1994 Aug; 26(4):1872. PubMed ID: 8066609
    [No Abstract]   [Full Text] [Related]  

  • 10. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatally induced transplantation tolerance to primarily vascularised cardiac allografts is not donor-specific.
    West LJ; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):184-5. PubMed ID: 7878966
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged cardiac xenograft survival is induced by intrathymic splenocyte injection.
    Sheffield CD; Hadley GA; Dirden BM; Bartlett ST
    J Surg Res; 1994 Jul; 57(1):55-9. PubMed ID: 8041149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to experimental cardiac allografts but not xenografts is induced after simultaneous neonatal intrathymic inoculation with allo and xenogeneic cells.
    Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
    Transplant Proc; 1996 Apr; 28(2):719-20. PubMed ID: 8623363
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of graft function in rodent models of heart transplantation.
    Martins PN
    Microsurgery; 2008; 28(7):565-70. PubMed ID: 18767132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
    Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isograft and allograft control studies for murine cardiac transplantation.
    Smith JA; Mottram PL; Mirisklavos A; Mason A; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1039-42. PubMed ID: 3547848
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
    Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
    Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
    [No Abstract]   [Full Text] [Related]  

  • 20. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.